サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1319085

女性の健康市場：年齢別（13-17歳、18-35歳、36歳以上）、流通チャネル別（病院、オンライン、小売）、用途別-2023-2030年の世界予測

Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
女性の健康市場：年齢別（13-17歳、18-35歳、36歳以上）、流通チャネル別（病院、オンライン、小売）、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性の健康の世界市場は、2023年にCAGR 8.91%で432億3,000万米ドル、2030年には驚異的な789億米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の女性の健康市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.女性の健康の世界市場規模および予測は？

2.予測期間中、世界の女性の健康市場を形成するCOVID-19の阻害要因と影響は？

3.女性の健康の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.女性の健康の世界市場における競争戦略は？

5.女性の健康の世界市場における技術動向と規制の枠組みは？

6.女性の健康の世界市場における主要ベンダーの市場シェアは？

7.女性の健康の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 女性のホルモンバランスの乱れや慢性疾患の増加
      • スーパーフードの増加傾向と女性向けのマルチビタミンの入手可能性の増加
      • 天然および植物ベースの健康補助食品に対する女性の傾向
    • 抑制要因
      • 高額な臨床治療費
    • 機会
      • ホルモン障害の治療薬開発に向けた研究開発活動の活発化
      • 女性の健康を改善するために世界中の政府が開始した有利な政策
    • 課題
      • 薬の摂取に伴う副作用
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 女性の健康市場年齢別

  • 13～17歳
  • 18～35歳
  • 36歳以上

第7章 女性の健康市場：流通チャネル別

  • 病院
  • オンライン
  • 小売り

第8章 女性の健康市場：用途別

  • 避妊薬
  • 子宮内膜症と子宮筋腫
  • ホルモン性不妊症
  • 閉経
  • 多嚢胞性卵巣症候群
  • 閉経後骨粗鬆症

第9章 南北アメリカの女性の健康市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の女性の健康市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの女性の健康市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 投資、資金調達
    • 受賞・表彰・拡大

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2022 VS 2030 (%)
  • FIGURE 5. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 6. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. WOMEN'S HEALTH MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. WOMEN'S HEALTH MARKET DYNAMICS
  • FIGURE 9. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 5. WOMEN'S HEALTH MARKET SIZE, BY 13-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. WOMEN'S HEALTH MARKET SIZE, BY 36 YEARS & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 9. WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOMEN'S HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. WOMEN'S HEALTH MARKET SIZE, BY ENDOMETRIOSIS & UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. WOMEN'S HEALTH MARKET SIZE, BY HORMONAL INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. WOMEN'S HEALTH MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. WOMEN'S HEALTH MARKET SIZE, BY POSTMENOPAUSAL OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. WOMEN'S HEALTH MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA04E4A

The Global Women's Health Market is forecasted to grow significantly, with a projected USD 43.23 billion in 2023 at a CAGR of 8.91% and expected to reach a staggering USD 78.90 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Women's Health Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Women's Health Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Age, market is studied across 13-17 Years, 18-35 Years, and 36 Years & Above. The 18-35 Years commanded largest market share of 41.01% in 2022, followed by 36 Years & Above.

Based on Distribution Channel, market is studied across Hospital, Online, and Retail. The Retail commanded largest market share of 62.12% in 2022, followed by Hospital.

Based on Application, market is studied across Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome, and Postmenopausal Osteoporosis. The Polycystic Ovary Syndrome commanded largest market share of 23.23% in 2022, followed by Contraceptives.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.34% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Women's Health Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Women's Health Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women's Health Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women's Health Market?

4. What is the competitive strategic window for opportunities in the Global Women's Health Market?

5. What are the technology trends and regulatory frameworks in the Global Women's Health Market?

6. What is the market share of the leading vendors in the Global Women's Health Market?

7. What modes and strategic moves are considered suitable for entering the Global Women's Health Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Women's Health Market, by Age, 2022 vs 2030
  • 4.3. Women's Health Market, by Distribution Channel, 2022 vs 2030
  • 4.4. Women's Health Market, by Application, 2022 vs 2030
  • 4.5. Women's Health Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
      • 5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
      • 5.1.1.3. Inclination of women towards natural and plant based health supplements
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
      • 5.1.3.2. Favorable policies initiated by governments worlwide to improve women's health
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects associated with consumption of drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Women's Health Market, by Age

  • 6.1. Introduction
  • 6.2. 13-17 Years
  • 6.3. 18-35 Years
  • 6.4. 36 Years & Above

7. Women's Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Online
  • 7.4. Retail

8. Women's Health Market, by Application

  • 8.1. Introduction
  • 8.2. Contraceptives
  • 8.3. Endometriosis & Uterine Fibroids
  • 8.4. Hormonal Infertility
  • 8.5. Menopause
  • 8.6. Polycystic Ovary Syndrome
  • 8.7. Postmenopausal Osteoporosis

9. Americas Women's Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women's health segment.
      • 12.3.1.2. Unified Women's Healthcare acquires menopause care platform Gennev.
      • 12.3.1.3. Carlyle and PAI on women's healthcare.
      • 12.3.1.4. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Onsite Women's Health and Volpara Health Announce National Partnership.
      • 12.3.2.2. HempStreet announces strategic partnership with Gynica.
    • 12.3.3. Investment & Funding
      • 12.3.3.1. Women's health startup Iron Health launches with $4.5M.
      • 12.3.3.2. Kiran Mazumdar Shaw invests in women's health platform Gytree.com.
      • 12.3.3.3. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
    • 12.3.4. Award, Recognition, & Expansion
      • 12.3.4.1. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing